The injection is supplied in 100 mg and 500 mg single-dose vials
Dr Reddy’s Laboratories announced the launch of Pemetrexed for Injection, 100 mg and 500 mg single-dose vials, the generic equivalent of ALIMTA (pemetrexed for injection) in the US Market approved by the US Food and Drug Administration (US FDA).
The ALIMTA brand and generic had US sales of approximately $1239 million MAT for the most recent twelve months ending in March 2022 according to IQVIA Health.
Dr Reddy’s Pemetrexed for Injection is supplied in 100 mg and 500 mg single-dose vials.
Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.
